CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totaling 100,000 shares, a growth of 102.6% from the December 31st total of 49,357 shares. Based on an average daily trading volume, of 73,481,118 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 73,481,118 shares, the short-interest ratio is currently 0.0 days.

CNBX Pharmaceuticals Price Performance

Shares of CNBX stock opened at $0.00 on Friday. CNBX Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.02.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.